Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PediaVision was a medical technology company that developed the Spot Vision Screener, a handheld device designed to revolutionize pediatric vision screening. The device uses sophisticated optics and algorithms to quickly and non-invasively detect common vision issues such as near-sightedness, far-sightedness, and blurred vision in children as young as six months. By providing automated, easy-to-understand results, the technology enables early intervention for conditions like amblyopia. The company was acquired by Welch Allyn in 2012, and its technology remains a gold standard in primary care and school-based screening programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PediaVision.